Cargando…
Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors
PURPOSE: Gastroenteropancreatic neuroendocrine tumors are a heterogeneous group of low incidence neoplasms characterized by a low proliferative activity and slow growth. Their response to targeted therapies is heterogeneous and often does not lead to tumor shrinkage. Thus, evaluation of the therapeu...
Autores principales: | Merino-Casabiel, X., Aller, J., Arbizu, J., García-Figueiras, R., González, C., Grande, E., Jiménez-Fonseca, P., Sevilla, M. I., Capdevila, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223716/ https://www.ncbi.nlm.nih.gov/pubmed/29766455 http://dx.doi.org/10.1007/s12094-018-1881-9 |
Ejemplares similares
-
Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development
por: Garcia-Carbonero, Rocio, et al.
Publicado: (2015) -
Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review
por: Grande, Enrique, et al.
Publicado: (2019) -
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)
por: González-Flores, E., et al.
Publicado: (2018) -
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program
por: Sevilla, Isabel, et al.
Publicado: (2016) -
Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria
por: Sandvik, O. M., et al.
Publicado: (2015)